MDPI and ACS Style
Marconi, S.; Croce, M.; Chiorino, G.; Rossi, G.; Guana, F.; Profumo, A.; Ostano, P.; Alama, A.; Longo, L.; De Luca, G.;
et al. A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. Cancers 2022, 14, 3412.
https://doi.org/10.3390/cancers14143412
AMA Style
Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, Ostano P, Alama A, Longo L, De Luca G,
et al. A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. Cancers. 2022; 14(14):3412.
https://doi.org/10.3390/cancers14143412
Chicago/Turabian Style
Marconi, Silvia, Michela Croce, Giovanna Chiorino, Giovanni Rossi, Francesca Guana, Aldo Profumo, Paola Ostano, Angela Alama, Luca Longo, Giuseppa De Luca,
and et al. 2022. "A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients" Cancers 14, no. 14: 3412.
https://doi.org/10.3390/cancers14143412